Topics

Glioblastoma | Prognosis

Home > Publications > Topics > Glioblastoma > Prognosis

□ OVERVIEW

□ ARTIFICIAL INTELLIGENCE

■ BIOMARKERS

□ BLOOD GROUP 0

□ BODY MASS INDEX

□ CAROTID ARTERY CALCIUM SCORE

□ CELLULAR HETEROGENEITY

□ CEREBELLAR

□ CIRCULATING CELLS

□ CONTRAST ENHANCEMENT

□ CUPROPTOSIS

□ EDEMA

□ ELDERLY PATIENTS

□ EPILEPSY

□ EXTRACELLULAR VESICLES

□ FIBRINOGEN

□ FRAILTY

□ GENE EXPRESSION

□ GLIOSARCOMA

□ KI-67

□ IDH MUTATION

□ IMMUNOTHERAPY

□ LOCATION OF THE TUMOR

□ MAGNETIC RESON IMAGING

□ METABOLIC SYNDROME

□ METASTASES

□ MGMT METHYLATION

□ MULTIFOCAL TUMOR

□ NEUROGENIC ZONES

□ NLR

□ NOMOGRAMS

□ NONCONTRAST-ENHANCED TUM

□ OLFACTORY FUNCTION

□ PLR

□ POSITRON EMISSION TOMOGR

□ PREOPERATIVE BLOOD EL

□ PREOPERATIVE TUMOR GROWTH

□ PRETREATMENT TUMOR SHAPE

□ PROGNOSTIC FACTORS

■ PROGNOSTIC SCORES

□ PROGRESSION

□ RE-RESECTION

■ RECURRENCE

□ RESECTION EXTENT

□ RESPONSE

□ SEX-SPECIFIC DIFFERENCES

□ STUPP PROTOCOL

□ SURGERY

SURVIVAL

□ OVERALL SURVIVAL

□ CONDITIONAL SURVIVAL

□ POSTOPERATIVE SURVIVAL

□ SHORT-TERM SURVIVAL

□ LONG-TERM SURVIVAL

□ EXTREME LONG-TERM SURVIVAL

□ TEMPORAL MUSCLE THICKNESS

□ TESTOSTERONE

□ THERAPY TIMING

□ TUMOR TREATING FIELDS